483
Chengdu Shengnuo Biopharm Co LtdChengdu Shengnuo Biopharm Co Ltd – FDA 483, Sep 8, 2023
Record Details
An FDA inspection of Chengdu Shengnuo Biopharm Co Ltd, a drug manufacturer in Chengdu, China, revealed significant deficiencies in the firm's quality unit regarding manufacturing records. The firm failed to ensure that records were complete, clear, accurate, contemporaneous, and traceable, leading to potential mix-ups, inadequate procedure adherence, and incomplete documentation.
View Company Profile
ID · 3a5fc8ce-c04d-40a6-8c94-70d6a944c6dc
Other documents for Chengdu Shengnuo Biopharm Co Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.